Bone marrow‐derived dendritic cells from experimental allergic encephalomyelitis induce immune tolerance to EAE in Lewis rats

We have previously shown that dendritic cells (DC), upon being pulsed in vitro with encephalitogenic myelin basic protein peptide 68–86 (MBP 68–86) and injected subcutaneously (s.c.) back to healthy Lewis rats, transfer immune tolerance to experimental allergic encephalomyelitis (EAE) induced by immunization with MBP 68–86 and Freund's complete adjuvant (FCA). We here assumed that DC become pulsed in EAE rats, and that expansion in vitro of such ‘in vivo pulsed EAE‐DC’ might also have the capacity to induce immune tolerance to EAE, thereby eliminating the need for in vitro pulsing of DC with autoantigens which are still unknown in many autoimmune diseases in the human. In the present study, EAE‐DC were generated from bone marrow of Lewis rats, with EAE induced with MBP 68–86 + FCA, and expanded in vitro by culture with GM‐CSF and IL‐4. In comparison with DC from normal rats, EAE‐DC exhibited higher viability in the absence of growth factors, and presented specific antigen to naïve T cells in vitro. The DC derived from both EAE and healthy rats stimulated strong proliferation in an antigen‐independent manner, lasting for 4 weeks after DC were s.c. injected into healthy rats. During this time, injection of EAE‐DC did not induce clinical EAE. However, when these rats were immunized with MBP 68–86 + FCA, subsequent EAE was dramatically suppressed, and was associated with increased IFN‐γ expression, nitric oxide production, gradually reduced proliferation and cell apoptosis, compared with PBS‐injected control EAE rats. LPS‐treated DC did not induce tolerance, suggesting that the tolerance is mediated by an immature stage of DC. These observations support the hypothesis that EAE‐DC can transfer immune tolerance to EAE, thereby omitting the step of characterizing specific autoantigen. Omitting the step of loading DC with antigen not only eliminates the extremely complex procedure of defining pathogenically‐relevant autoantigens, but also avoids the risk of inducing immunogenicity of DC in the treatment of autoimmune diseases.

[1]  M. Roncarolo,et al.  Differentiation of T Regulatory Cells by Immature Dendritic Cells , 2001, The Journal of experimental medicine.

[2]  Nina Bhardwaj,et al.  Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells , 2001, The Journal of experimental medicine.

[3]  W. Brück,et al.  Molecular Mechanisms of High-Dose Antigen Therapy in Experimental Autoimmune Encephalomyelitis: Rapid Induction of Th1-Type Cytokines and Inducible Nitric Oxide Synthase1 , 2000, The Journal of Immunology.

[4]  H. Link,et al.  Autoantigen‐pulsed dendritic cells induce tolerance to experimental allergic encephalomyelitis (EAE) in Lewis rats , 2000, Clinical and experimental immunology.

[5]  B. Levine,et al.  Efficient priming of protein antigen-specific human CD4(+) T cells by monocyte-derived dendritic cells. , 2000, Blood.

[6]  Bolund,et al.  Characterization of Murine Dendritic Cells Derived from Adherent Blood Mononuclear Cells In Vitro , 2000, Scandinavian journal of immunology.

[7]  Y. Aizawa,et al.  Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha. , 2000, Journal of hematotherapy & stem cell research.

[8]  S. Wittmer,et al.  Failure to Suppress the Expansion of the Activated Cd4 T Cell Population in Interferon γ–Deficient Mice Leads to Exacerbation of Experimental Autoimmune Encephalomyelitis , 2000, The Journal of experimental medicine.

[9]  R. Steinman,et al.  The Induction of Tolerance by Dendritic Cells That Have Captured Apoptotic Cells , 2000, The Journal of experimental medicine.

[10]  R. Gorczynski,et al.  Dendritic Cells Genetically Engineered to Express Fas Ligand Induce Donor-Specific Hyporesponsiveness and Prolong Allograft Survival1 , 2000, The Journal of Immunology.

[11]  鄭 智茵.  Generation of dendritic cells from adherant cells of cord blood by culture with GM-CSF, IL-4 and TNF-α , 2000 .

[12]  T. Owens,et al.  IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines. , 2000, Journal of immunology.

[13]  P. Kalinski,et al.  T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. , 1999, Immunology today.

[14]  W. Cowden,et al.  IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. , 1999, Journal of immunology.

[15]  A. Sher,et al.  The role of dendritic cells in the induction and regulation of immunity to microbial infection. , 1999, Current opinion in immunology.

[16]  Onji,et al.  Transfer of dendritic cells (DC) ex vivo stimulated with interferon‐gamma (IFN‐γ) down‐modulates autoimmune diabetes in non‐obese diabetic (NOD) mice , 1999, Clinical and experimental immunology.

[17]  R. Merchant,et al.  Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis. , 1999, Journal of immunology.

[18]  H. Link,et al.  Mechanisms of recovery from experimental allergic encephalomyelitis induced with myelin basic protein peptide 68–86 in Lewis rats: a role for dendritic cells in inducing apoptosis of CD4+ T cells , 1999, Journal of Neuroimmunology.

[19]  J. M. Mansfield,et al.  IFN-gamma-dependent nitric oxide production is not linked to resistance in experimental African trypanosomiasis. , 1999, Cellular immunology.

[20]  B. Pulendran,et al.  Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  T. Luger,et al.  Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. , 1999, Journal of immunology.

[22]  Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. , 1999, Blood.

[23]  M. S. Williams,et al.  Nitric oxide synthase plays a signaling role in TCR-triggered apoptotic death. , 1998, Journal of immunology.

[24]  P. Holt,et al.  Resting Respiratory Tract Dendritic Cells Preferentially Stimulate T Helper Cell Type 2 (Th2) Responses and Require Obligatory Cytokine Signals for Induction of  Th1 Immunity , 1998, The Journal of experimental medicine.

[25]  O. Cummings,et al.  Instillation of allogeneic lung macrophages and dendritic cells cause differential effects on local IFN‐7 production, lymphocytic bronchitis, and vasculitis in recipient murine lungs , 1998, Journal of leukocyte biology.

[26]  R. Zinkernagel,et al.  Dendritic Cells Induce Autoimmune Diabetes and Maintain Disease via De Novo Formation of Local Lymphoid Tissue , 1998, The Journal of experimental medicine.

[27]  Watson,et al.  A long‐lasting interferon‐γ response is induced to a single inoculation of antigen‐pulsed dendritic cells , 1998, Immunology.

[28]  A. Mowat,et al.  Expanding dendritic cells in vivo enhances the induction of oral tolerance. , 1998, Journal of immunology.

[29]  L. Virág,et al.  Nitrergic mechanism of DC-mediated T-cell elimination. , 1998, Immunology today.

[30]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[31]  M. Moser,et al.  The immune response induced in vivo by dendritic cells is dependent on B7-1 or B7-2, but the inhibition of both signals does not lead to tolerance. , 1998, International immunology.

[32]  A. Enk,et al.  Induction of tolerance by IL-10-treated dendritic cells. , 1997, Journal of immunology.

[33]  E. Clementi,et al.  Autocrine Nitric Oxide Modulates CD95-induced Apoptosis in γδ T Lymphocytes* , 1997, The Journal of Biological Chemistry.

[34]  H. Hartung,et al.  Apoptosis of myelin-reactive T cells induced by reactive oxygen and nitrogen intermediates in vitro. , 1997, Cellular immunology.

[35]  E. Clementi,et al.  Autocrine nitric oxide modulates CD95-induced apoptosis in gammadelta T lymphocytes. , 1997, The Journal of biological chemistry.

[36]  P. Linsley,et al.  Ex vivo treatment of antigen-presenting cells with CTLA4Ig and encephalitogenic peptide prevents experimental autoimmune encephalomyelitis in the Lewis rat. , 1996, Journal of immunology.

[37]  V. Maino,et al.  Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations , 1995, The Journal of experimental medicine.

[38]  V. Wahn,et al.  Nitric oxide induces apoptosis in mouse thymocytes. , 1995, Journal of immunology.

[39]  T. Starzl,et al.  Microchimerism, dendritic cell progenitors and transplantation tolerance , 1995, Stem cells.

[40]  A. Taylor-Robinson,et al.  Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells , 1994, European journal of immunology.

[41]  C. Snapper,et al.  Towards a comprehensive view of immunoglobulin class switching. , 1993, Immunology today.

[42]  M. Clare-Salzler,et al.  Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer. , 1992, The Journal of clinical investigation.

[43]  R. Coffman,et al.  Lymphokine control of in vivo immunoglobulin isotype selection. , 1990, Annual review of immunology.

[44]  T. Olsson,et al.  In Vivo Treatment of Rats with Monoclonal Anti‐T‐Cell Antibodies , 1985, Scandinavian journal of immunology.